Integrative approaches that combine multiple forms of data can more accurately capture pathway associations and so provide a comprehensive understanding of the molecular mechanisms that cause complex diseases. Association analyses based on single nucleotide polymorphism (SNP) genotypes, copy number variant (CNV) genotypes, and gene expression profiles are the 3 most common paradigms used for gene set/pathway enrichment analyses. Many work has been done to leverage information from 2 types of data from these 3 paradigms. However, to the best of our knowledge, there is no work done before to integrate the 3 paradigms all together. In this article, we present an integrated analysis that combine SNP, CNV, and gene 
| INTRODUCTION
Many human complex diseases, including Alzheimer's disease, schizophrenia, and cancer are the leading cause of death around the world.
These complex diseases are major biomedical challenges because they are common and require intensive and sophisticated analysis.
The disease-gene mapping represents a powerful technique to identify the set of genes and biological processes associated with any signs influenced by inheritance, including human diseases.
The genetic variants can be classified to 2 classes. First, single nucleotide variants (single nucleotide polymorphisms [SNPs] ) which are the most popular class of genetic variation among people. Many association studies use SNP arrays to detect the genetic changes related with complex diseases. These studies aim to identify if there are a specified set of SNPs with frequencies that differ between case and control groups.
1,2 Second, structural variation, including copy number variants (CNVs), which refer to all base pairs that differ between individuals and that are not single nucleotide variants. Such variation includes insertion-deletions (indels), block substitutions, inversions of DNA sequences, and copy number differences.
Recently, scientists believe that CNVs can be the cause of much of human diseases. 3, 4 It was also shown in Reference 5, that SNPs and CNVs coexist throughout the genome, and so they influence one another's genotype measurement. Integrated association studies for SNPs and
CNVs have shown that the raw intensity data generated during SNP genotyping can be also mined for copy-number information. A large number of copy-number alterations can be detected using a number of common SNP arrays. Ideally, every DNA sample would be simultaneously queried for SNPs and CNVs in a single, integrated analysis. 6 On the other hand, variation in gene expression is also an important mechanism underlying susceptibility to complex disease. 7, 8 Gene expression regulation by epigenetic modifications, small RNAs, and other factors can alter protein translation, which in turn affects intracellular dynamics and can contribute to a disease phenotype.
Association studies illustrate that joint analyses of genomic data increase the power to detect real associations when compared with gene set methods that use only 1 genomic data type. In other words, valuable associations may be discarded in single data type analyses.
Combining data from multiple studies, have the statistical power to detect a robust set of genes that are altered due to tumor tissues. It is well-known that the most common factors that can contribute to cancer progression are alterations in the transcriptome, mutations in the DNA sequence, and variations in the genome. All these factors have important and different effects on tumor development. Therefore, SNP, CNV, and gene expression analysis may target essentially a consistent set of genes, providing the theoretical basis for the joint analysis of SNP, CNV, and gene expression data.
Other methodologies for integrative genomic analysis in cancer have been studied previously. The review presented in Reference 9
summarizes a number of different tools and algorithms used in this area. The article classifies these methods into statistical, machine learning, gene set, network, and other analysis techniques.
Many work has been done to perform an integrated analysis using genetic and gene expression data.
In Reference 10, the authors have developed a single statistical framework, Gene Set Association Analysis (GSAA), that simultaneously measures genome-wide patterns of genetic variation and gene expression variation to identify sets of genes that are differentially expressed and thus can be used as markers associated to the studied trait. They compared the performance of GSAA with 3 other gene set methods that use only 1 genomic data source; GSAA-SNP (a SNPbased GSAA), GSEA (a previously developed Gene Set Enrichment Analysis 11 that performs expression based enrichment analysis), and
GSEAndes (a variant of GSEA that ranks genes based on the absolute value of their expression differences). Using extensive simulation studies, they illustrated that GSAA outperforms each of 3 other methods and that joint analyses reduced the false discovery rate (FDR) in all simulated scenarios and increased the power in almost all simulated scenarios. A working hypothesis that the joint analysis of genetic and proteomic data will provide more information for modeling disease susceptibility than single-view methods is presented in Reference 12. Using average classification errors across 100 data sets, it was illustrated that having multiple types of data is more beneficial when the etiological model is complex and 1 or more variables may be missing. An integrated analysis of copy number variations and gene expression is proposed in Reference 13. The concurrent genome-wide analysis was done on non-smoking female lung adenocarcinoma. The analysis aim to identify genes/pathways associated with tumorigenesis.
All the above articles integrate only 2 of the 3 most common genetic data: SNP data, CNV data, and gene expression data. Here, in this article, we have presented an integrated analysis to combine the 3 widely used association analysis methods: analysis based on SNP genotypes, CNV genotypes, and gene expression profiles. Three cancer datasets are used in the study: lung adenocarcinoma, diffuse intrinsic pontine glioma (DIPG), and head and neck squamous cell carcinoma (HNSCC). We provided 2 different ways of comparison:
1 based on the union of the gene lists generated from the SNP, CNV, and gene expression data, and the other is based on the integration of gene association scores. Both ways show that the pathways and gene ontology (GO) terms resulted from combining the 3 data are more related to the studied cancer disease than the ones that result from combining any pair of them. This support our conclusion that integrating the 3 data all together gives better association results than the pairwise integration.
In summary, our main contributions in this article are:
• We present an integrated analysis that combine SNP data, CNV data, and gene expression data to generate 1 list of genes that are altered by the studied disease.
• We show that SNP, CNV, and gene expression data generate consistent lists of genes.
• We provide 2 different methods of comparison to demonstrate that by using the 3 data together, the enriched GO terms and pathways are more associated to the studied disease than by using only 2 types of data.
• We strengthen our work using 3 different datasets: lung adenocarcinoma, DIPG diseases, and HNSCC.
| MATERIALS AND METHODS

| Datasets
Three different case-control datasets are used in this study. All datasets are downloaded from Gene Expression Omnibus database (GEO). 14 The first one, GSE33356, 13 is designed to study lung adeno- 
| Generation of genes data
Three different lists of genes are generated from SNP, CNV, and gene expression data of GSE33356, GES50025, and GSE33232 datasets.
| SNP data
First, we conducted systematic quality control on the raw genotyping data (Affymetrix SNP 6.0) to filter both unqualified samples and
SNPs. The samples with overall genotype completion rates <90%
were excluded from further analysis. Also we kept only the SNPs that had minor allele frequency (MAF) >0.05. For each SNP, the associated gene is retrieved from the Affymetrix annotation file version 35 . 17 SNPs that were within the region 1 kb upstream of the transcription start site (TSS) to the end of the transcribed bases are assigned to be associated with a gene.
| CNV data
To investigate genomic alternations, we used the Affymetrix SNP 6.0
array. The microarray data, represented in raw CEL files, were imported into the PennCNV 18 to perform the CNV analysis. The associated gene of each CNV is obtained after searching through the Affymetrix annotation file version 35. 17 Copy Number Polymorphism (CNPs) that were within the region 1 kb upstream of the TSS to the end of the transcribed bases are assigned to be associated with a gene.
| Gene expression data
For the GSE33356, GSE50025, and GSE33232 datasets, we used the Affymetrix U133plus2.0, Illumina HT-12V4 BeadChip, and Affymetrix HuEx 1.0 GeneChips microarrays, respectively. First, the data is split to case and control classes. Then, a t test is applied to get the genes that are differentially expressed between the 2 phenotypic classes.
The genes that did not pass the t test are excluded from the output genes list.
| Gene set association analysis
We modified the GSAA described by Qing Xiong et al 10 to use any 2 or 3 of the 3 genes lists generated from the SNP, CNV, and gene expression data. In Reference 10, the GSAA was based on multiple layers of association tests. We modified their multi-level procedure to include these 7 individual calculations: (1) computation of a single-SNP association score; (2) computation of a single-CNP association score; (3) computation of a differential gene expression score;
(4) computation of a SNP set association score; (5) computation of a CNP set association score; (6) computation of a gene association score; and (7) a gene set association test. An overview of the used methodology is illustrated in Figure S1 , Supporting Information. The following describes each of the components in detail.
| Computation of a single-SNP association score
To calculate single-SNP association scores, a basic allelic association test is applied on each SNP. This test is given by a simple χ 2 test, based on frequency differences in major/minor alleles between the case-control classes. Each SNP has a score that is equal to the Pvalue of the χ 2 test.
| Computation of a single-CNP association score
The PennCNV program implements a very preliminary functionality of case-control association analysis, to identify a stretch of probes that tend to have copy number changes in cases vs controls using
Fisher's exact test. The score of each CNP is defined to be the P-value of the Fisher's exact test.
| Computation of a differential gene expression score
Differential expression scores should be able to discriminate the list of genes that are differentially expressed between the case-control classes. A t test is applied to each gene and the P-value of the test is assigned as a score to the gene.
| Computation of a SNP set association score
Many problems can raise when genotype data are used in gene set analyses. This is because multiple SNPs can be mapped to the same gene if we used the mapping method described in the previous section. So, we define the SNP set association score for a gene to be the minimum single-SNP score from all the single-SNP scores assigned to that gene.
| Computation of a CNP set association score
Similar to the SNPs, multiple CNPs can be mapped to the same gene if we used the mapping method described in the previous section. So, we assign the minimum single-CNP score, over all the CNPs assigned to a given gene, to the CNP set association score for that gene.
| Computation of a gene association score
Given SNP set association score, CNP set association score, and differential gene expression score for each gene, we can combine any 2 scores or the 3 all together to generate a single gene association score. The result will be 4 different lists of (gene-score) pairs. As we depend on P-values derived from different tests to present the scores of a gene, the Fisher's combined probability test 19 is used to combine the P-values to produce the integrative gene association score.
where K is the number of independent tests, here K = 2 or 3, to indicate any 2 or 3 from the SNP-based test, CNP-based test and expression-based test, and p ij is the P-value for gene i in test j. This combination does not scale for biological impact of each data source.
So, the tests here are independent as the P-value for each of the 3 data do not represent the same probability construct.
| Gene set association test
We used weighted Kolmogorov-Smirnov (K-S) test, described in Ref-
erence 10, to identify the gene sets that are the most related to the given phenotype. The weighted K-S test depend on the gene association scores of the genes of each gene set to detect the sets that contain the highly ranked genes.
| RESULTS
The 3 datasets GSE33356, GSE50025, and GSE33232 are used to demonstrate that integrating SNP, CNV, and gene expression data gives better association results than integrating any pair of them.
| Consistency between SNP, CNV, and gene expression results
To show the consistency between the lists of genes generated from SNP, CNV, and gene expression data, the dataset GSE33356 is used as an example. First, we selected the CNV driven genes with P- We next studied the pairwise overlap between the top 2000 genes driven by SNP, CNV, and gene expression data. Table 1 Each of the 4 gene lists is submitted to the Enrichr tool 25 to search for pathways and ontologies. The studied pathways are: KEGG, 26 WikiPathways, 27 Reactome, 28 and Biocarta. 29 For the ontologies, we searched for the gene-set libraries created from the 3 GO trees 30 : GO biological processes, GO cellular components, and GO molecular functions. The combined scores and the Benjamini-Hochberg adjusted Pvalues of the resulted pathways and ontologies are used as the measure of comparison; large combined scores with small adjusted P-values are assigned to the pathways and ontologies that are more related to the studied disease. The combined score is a score calculated by multiplying the combined P-value computed using the Fisher's exact test with the z-score of the deviation from the expected rank:
The top 10 ranked homo sapiens pathways and ontologies from the enrichment study of the 4 gene lists are illustrated in Figures S3 to S8. Tables 2 and 3 show the mean and variance of the combined scores and the adjusted P-values generated by combining "SNP-CNVgene expression," "SNP-gene expression," "CNV-gene expression,"
and "SNP-CNV" gene lists for both pathways and ontologies. A student's t test is applied to calculate the difference between the means of the scores or the P-values of "SNP-CNV-gene expression" and each other pair. The confidence intervals (CI) and the P-value of the test are shown in the tables. Also, the effect sizes, illustrated in the tables are calculated according to Cohen's d formula: From the results, we can conclude that the enrichment study of SNP with CNV and gene expression data gives better association results than the study of any pair of them. Figures 1 and S9 also empathize our conclusion.
| Comparison based on gene set association score
Four different lists of genes and their scores are generated; 3 of them are created by integrating the scores of each pair of data: "SNP-gene expression," "CNV-gene expression," and "SNP-CNV." The fourth list is generated by integrating the scores of "SNP-CNV-gene expression" all together. The integration here is done using the methodology described Box plots comparing combined scores of "SNP-CNV-Expr.," "SNP-Expr.," "CNV-Expr.," and "SNP-CNV" using: GES33356 (A, B) , GSE50025 (C, D), and GSE33232 (E, F). As it is clear from the figures, the box plots of "SNP-CNV-Expr." are always above or at the same level of other box plots. This means integrating "SNP-CNV-Expr." gives higher or equal scores for the extracted pathways and ontologies than integrating any pair of the 3 gene lists Comparing the NESs and P-values of the GSEA canonical pathways searched using the 4 gene lists generated from the GSE33356 and GSE50025 datasets. CI is calculated from the t test of the difference between the NES or P-values of the integration of SNP-CNV-Expr gene lists and the given pair. P-value is the one associated with the test Abbreviations: CI, confidence interval; CNV, copy number variant; GSEA, Gene Set Enrichment Analysis; NES, Normalized Enrichment Score; SNP, single nucleotide polymorphism.
TABLE 5
Comparing the NESs and P-values of the GSEA GO terms searched using the 4 gene lists generated from the GSE33356 and GSE50025 datasets. CI is calculated from the t test of the difference between the NEs or P-values of the integration of SNP-CNV-Expr gene lists and the given pair. P-value is the one associated with the test analysis results across gene sets. High NES with small P-value indicates more association between the gene set and the given disease. GSEA determines NES as follows: NES = Actual ES Mean ESs against all permutations of the dataset ð Þ First, determine the actual Enrichment Score ES for each gene set. ES reflects the degree to which this set is overrepresented at the top or bottom of a ranked list of genes. To adjust for variations in the gene set size, the dataset is randomly permutated 1000 times and the ES for the gene set is then recalculated for each permutation. Finally, the NES for each gene set is the ratio between the actual ES and the mean of ESs of that set against all the permutations.
Figures S10 to S15 show the top 10 ranked significant pathways and GO terms. Tables 4 and 5 show the mean and variance of the NESs and the P-values generated by combining "SNP-
Box plots comparing normalized enrichment scores of "SNP-CNV-Expr.," "SNP-Expr.," "CNV-Expr.," and "SNP-CNV" using: GES33356 (A, B), GSE50025 (C, D), and GSE33232 (E, F). As it is clear from the figures, the box plots of "SNP-CNV-Expr." are always above or at the same level of other box plots. This means integrating "SNP-CNV-Expr." gives higher or equal scores for the extracted canonical pathways and GO terms than integrating any pair of the 3 gene lists CNV-gene expression," "SNP-gene expression," "CNV-gene expression," and "SNP-CNV" gene lists for both canonical pathways and GO terms. A student's t test is applied to get the difference between the means of the scores or the P-values of "SNP-CNV-gene expression" and each other pair. CI and P-value of the test are shown in the tables. Also, effect sizes, calculated as shown in the previous section, are illustrated in the tables. From the results, we can conclude again that the association study of SNP with CNV and gene expression data gives better results than the study of any pair of them. Figures 2 and S16 also approve our conclusion.
| DISCUSSION
An intensive work is done by many researches trying to investigate the factors that affect the propagation of tumor tissues. The associations between SNPs and a disease, CNVs and a disease or genes that are differentially expressed and a disease are widely studied before. 3, [31] [32] [33] Also, combining 2 of these factors to perform a joint analysis is discussed in many previous articles. However, to the best of our knowledge, no work has been done before to study the effect of integrating the 3 factors all together on the association results.
Despite the enormous success of SNP analysis studies in uncovering important genetic effects, the identified SNPs explain only a small proportion of the phenotypic variation, and the predictive power of these SNPs remains low for many complex diseases. 34 On the other hand, certain GO categories were identified from the genes overlapped by CNVs. by each gene is not strong. Also, GSEA does not depend on the "cuttoff" strategy. That is, it does not exclude any gene that does not meet some specified criteria from further analysis. This allows all genes to contribute to the analysis in different degrees. Here, we use
GSEA to obtain canonical pathways and ontologies. Normalized scores and P-values are used to identify pathways/ontologies most related to the studied cancer disease. Those are the ones that contain highly ranked genes.
GSEA depends generally on a predefined set of biological pathways/ontologies. This dependency may lead to inaccurate association results if the prior information about pathways/ontologies is incomplete or inaccurate. However, nowadays, there is an intensive work to increase the accuracy of the annotation functions which will help to increase the accuracy of the enrichment association results.
Our results show that performing a joint analysis using the 3 data (SNP, CNV, and gene expression data) gives a set of genes that are more associated to the studied disease than the genes that result from using only 2 types of these data. This conclusion is driven from Tables 2 to 5 . Figures 1 and 2 also approve our conclusion; as the box plots when using "SNP-CNV-Expr" data are almost all the time at higher or same level with other plots when using only 2 data types.
However, there is no pair of data that shows always better scores than using the 3 data all together.
Although the results derived from the 3 different datasets are consistent, it could be beneficial to study more cancer datasets in order to strengthen our conclusion. However, an area of future development is to adapt our methodology to integrate more genomic data sources such as: DNA methylation and microRNA expression.
| Ethical statement
No ethical approval is required for our study, as we did not conduct any experiments on human participants. All the data used here are obtained from previously published work.
